Cord Blood America, Inc. (OTC:CBAI.ob), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that it has purchased a minority interest in Stem Cells VIDAPLUS, a Spanish-owned company which preserves umbilical cord stem cells at the Institute of Transfusion [...]
{ 0 comments }
Cord Blood America, Inc. (OTC:CBAI.ob), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced yesterday that Matthew Schissler, CEO and co-founder, explains in detail the plans for the Company’s recapitalization in a ten-minute interview. The video and text of the [...]
{ 0 comments }
1.) As of today, there are now 158.1M + 35.7M = 193.8M shares outstanding, with today adding 22.6% more dilution … its now basically doubled over the course of the past year!!! 2.) The Liquid Surfaxin is the Lead Program, and it is targeted to a $75M/yr U.S.-only market opportunity, which is currently served by [...]
{ 0 comments }
How to profit from Biotech? The term Biotechnology, and its abbreviation, crept into the language in the late 1960s and early 1970s. It refers that set of technologies and companies that were concerned with understanding and mapping the human gene set. With the advance of biotechnology another terms bioterials was coined. This is used in [...]
{ 0 comments }